Using Systematic Reviews and Registers of Ongoing Trials for Scientific and Ethical Trial Design, Monitoring, and Reporting

Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition

Volumn , Issue , 2008, Pages 429-443

  Chalmers, Iain ^a  

^a UK COCHRANE CENTRE   (United Kingdom)

Author keywords

Ethical trial design; Patient monitoring; Premenstrual syndrome; Scientific trial design; Systematic review

Indexed keywords

EID: 84948750458     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470693926.ch24     Document Type: Chapter

References (68)

1. Knipschild P. Some examples of systematic reviews. In: Chalmers I, Altman DG, eds. Systematic reviews. London: BMJ Publishing Group, 1995:9-16.
2. Kupfer C. Differing perspectives: Is meta-analysis a reasonable alternative to large randomized trials? Paper presented at the 6th Ann Int Cochrane Colloquium. Baltimore, 22-26 October, 1998.
3. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 1998;338:1572-6.
4. Glass P, Avery GB, Subramanian KN, Keys MP, Sostek AM, Friendly DS. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 1985;313:401-4.
5. Commentary and questions session II. In: Flynn JT, Phelps DL, eds. Retinopathy of prematurity: problems and challenge. Birth defects original article series 24. White Plains, NY: March of Dimes Birth Defects Foundation, 1988:169-71.
6. Phelps DL, Watts JL. Early light reduction for preventing retinopathy of prematurity in very low birth weight infants (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
7. Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ 1996;313:1390-3.
8. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995;48:45-57.
9. Danish Research Ethics Committee System. Recommendation No. 20: controlled clinical trials - the influence of existing and newly acquired scientific results on the research ethical evaluation. Copenhagen: Danish Research Ethics Committee System,1997.
10. Goldbeck-Wood, S. Denmark takes lead on research ethics. BMJ 1998;316:1189.
11. Chalmers I. The perinatal research agenda: whose priorities? Birth 1991;18:137-41.
12. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ 1995;310:1315-18.
13. Altman DG. The scandal of poor medical research. BMJ 1994;308:283-4.
14. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998;317:1181-4.
15. Soares K, McGrath J, Adams C. Evidence and tardive dyskinesia [letter]. Lancet 1996;347:1696-7.
16. Dieppe P, Chard J, Tallon D, Egger M. Funding clinical research [letter]. Lancet 1999;353:1626.
17. Warlow C, Sandercock P, Dennis M, Wardlaw J. Research funding [letter]. Lancet 1999;353:2250.
18. Schierhout G, Roberts I. Hyperventilation therapy in acute traumatic brain injury (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
19. Schierhout G, Roberts I. Mannitol in acute traumatic brain injury (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
20. Alderson P, Roberts I. Corticosteroids in acute traumatic brain injury (Cochrane Review). In: The Cochrane Library, Issue 3, 1998. Oxford: Update Software, 1998.
21. Dorman PJ, Sandercock PA. Considerations in the design of clinical trials of neuroprotective therapy in acute stroke. Stroke 1996;27:1507-15.
22. Cuervo LG, Rodríguez MN, Delgado MB. Enema vs no enema during labor (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
23. O'Toole, L. Using systematically synthesised evidence to inform the funding of new clinical trials - the UK Medical Research Council approach. Paper presented at the 6th Ann Int Cochrane Colloquium. Baltimore, 22-26 October, 1998.
24. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT). Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-44.
25. Laupacis A. Research by collaboration. Lancet 1995;345:938.
26. Berlin JA, Colditz GA. The role of meta-analysis in the regulatory process for foods, drugs, and devices. JAMA 1999;281:830-4.
27. Chalmers I, Lindley R. Double standards on informed consent to treatment. In: Doyal L, Tobias JS, eds. Informed consent: respecting patients' rights in research, teaching and practice. London: BMJ Books, 2000.
28. Faculty of Pharmaceutical Medicine, Ethical Issues Working Group. Ethics in pharmaceutical medicine. Int J Pharmaceut Med 1998;12:193-8.
29. Hetherington J, Dickersin K, Chalmers I, Meinert CL. Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics 1989;84:374-80.
30. Roberts I. An amnesty for unpublished trials. One year on, many trials are unregistered and the amnesty remains open. BMJ 1998;317:763-4.
31. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-41.
32. Meinert CL. Toward prospective registration of clinical trials. Controlled Clin Trials 1988;9:1-5.
33. Dickersin K. Report from the panel on the Case for Registers of Clinical Trials at the 8th Annual Meeting of the Society for Clinical Trials. Controlled Clin Trials 1988;9:76-81.
34. International Collaborative Group on Clinical Trial Registries. Position paper and consensus statement on clinical trial registries. Clin Trials Meta-Analyses 1993;28:199-201.
35. Egger M, Davey Smith G. Meta-analysis: bias in location and selection of studies. BMJ 1998;316:61-6.
36. Harlan W. Current and future collaboration between the National Institutes of Health and the Cochrane Collaboration. Paper presented at the 6th Ann Int Cochrane Colloquium. Baltimore, 22-26 October, 1998.
37. Sykes R. Being a modern pharmaceutical company. Involves making information available on clinical trial programmes. BMJ 1998;317:1172.
38. Horton R, Smith R. Time to register randomised trials. Lancet 1999;354:1138-9.
39. Horton R, Smith R. Time to register randomised trials. BMJ 1999;319:865-6.
40. Tonks A. Registering clinical trials. BMJ 1999;319:1565-8.
41. Hampton JR. Alternatives to mega-trials in cardiovascular disease. Cardiovasc Drugs Therapy 1997;10:759-65.
42. Cowley AJ, Skene A, Stainer K, Hampton JR. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol 1993;40:161-6.
43. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270:1589-95.
44. Moore T. Deadly Medicine. New York: Simon and Schuster, 1995.
45. Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 1983;52:32C-36C.
46. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990;263:1405-8.
47. Lock S, Wells F. Preface to the second edition. In: Lock S, Wells F, eds. Fraud and misconduct in medical research. London: BMJ Publishing Group, 1996:xi-xii.
48. Chalmers I, Soll R. Progress and problems in establishing an international registry of perinatal trials. Controlled Clin Trials 1991;12:630.
49. Medical Research Council. MRC guidelines for good clinical practice in clinical trials. London: Medical Research Council, 1998.
50. Wallace M. Research information and the public interest. Paper presented at the BMJ Conf 50 Years of Clinical Trials: Past, Present and Future. 29-30 October, London.
51. Chalmers I. Improving the quality and dissemination of reviews of clinical research. In: Lock S, ed. The future of medical journals: in commemoration of 150 years of the British Medical Journal. London: BMJ Books, 1991:127-46.
52. Crowther CA, Alfirevic Z, Haslam RR. Antenatal thyrotropin-releasing hormone prior to preterm delivery (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2000.
53. Elbourne D. Using external evidence as the basis for stopping a trial: example of the antenatal TRH trial. Paper prepared for the BMJ Conf 50 Years of Clinical Trials: Past, Present, Future. 29-30 October, London.
54. DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. Lancet 1999;354:1983-8.
55. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators. N Engl J Med 1992; 327:227-33.
56. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988;260:1910-16.
57. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Int Med 1989;149:2694-8.
58. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986;2:57-66.
59. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;17:335-71.
60. Chalmers I, Haynes RB. Reporting, updating and correcting systematic reviews of the effects of health care. In: Chalmers I, Altman DG, eds. Systematic reviews. London: BMJ Publishing Group, 1995:86-95.
61. Smith R. What is publication? BMJ 1999;318:142.
62. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
63. Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA 1998;280:280-2.
64. Jefferson T, Deeks J. The use of systematic reviews for editorial peer-reviewing: a population approach. In: Godlee F, Jefferson T, eds. Peer review in health sciences. London: BMJ Books, 1999:224-34.
65. Delamothe T, Müllner M, Smith R. Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this. BMJ 1999;318:888-9.
66. Chalmers I, Hetherington J, Elbourne D, Keirse MJNC, Enkin M. Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989:39-65.
67. Chalmers I, Altman DG. How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet 1999;353:490-3.
68. Chalmers I. Foreword. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2000.